GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q3 2020
Top Holdings45 positions
TENET HEALTHCARE CORP COM NEW | 19.8M | $484.4M | 15.2% | $17.93 | +30.97% | 8 qtrssince 2018-Q4 | Unchanged 0 |
TAKEDA PHARMACEUTICAL CO LTD | 16.8M | $299.5M | 9.4% | $18.82 | -9.75% | 7 qtrssince 2019-Q1 | Increased 63 |
BAUSCH HEALTH COS INC | 15M | $232.4M | 7.3% | $22.43 | -33.66% | 8 qtrssince 2018-Q4 | Decreased 0 |
CIGNA CORP NEW | 1.3M | $221.9M | 7.0% | $157.84 | -3.45% | 8 qtrssince 2018-Q4 | Increased 61 |
HCA HEALTHCARE INC | 1.6M | $204.3M | 6.4% | $119.49 | -3.89% | 8 qtrssince 2018-Q4 | Decreased 0 |
MCKESSON CORP | 1.3M | $188.7M | 5.9% | $106.42 | +33.37% | 8 qtrssince 2018-Q4 | Increased 63 |
DXC TECHNOLOGY CO | 10.2M | $182.4M | 5.7% | $48.08 | -63.19% | 8 qtrssince 2018-Q4 | Decreased 0 |
| 698,442 | $131.5M | 4.1% | $4.10 | +87.32% | 2 qtrssince 2020-Q2 | Decreased 0 | |
HOLOGIC INC | 1.5M | $96.4M | 3.0% | $43.06 | +53.54% | 8 qtrssince 2018-Q4 | Decreased 0 |
VIACOMCBS INC | 3.4M | $96.3M | 3.0% | — | — | 4 qtrssince 2019-Q4 | Decreased 0 |
MERITOR INC | 3.9M | $81.1M | 2.5% | — | — | 8 qtrssince 2018-Q4 | Decreased 0 |
NUANCE COMMUNICATIONS INC | 2.4M | $79.9M | 2.5% | — | — | 8 qtrssince 2018-Q4 | Decreased 0 |
AMERISOURCEBERGEN CORP | 819,674 | $79.4M | 2.5% | $71.04 | +20.41% | 8 qtrssince 2018-Q4 | Decreased 0 |
F M C CORP | 694,509 | $73.6M | 2.3% | $52.60 | +70.45% | 8 qtrssince 2018-Q4 | Decreased 0 |
IQVIA Holdings Inc. | 418,985 | $66M | 2.1% | $115.32 | +34.22% | 8 qtrssince 2018-Q4 | Decreased 0 |
UNIVERSAL HLTH SVCS INC | 575,634 | $61.6M | 1.9% | $97.79 | +2.13% | 8 qtrssince 2018-Q4 | Decreased 0 |
CORTEVA INC | 1.7M | $48.1M | 1.5% | $25.80 | +4.45% | 4 qtrssince 2019-Q4 | Decreased 0 |
Marriott International, Inc. | 437,717 | $40.5M | 1.3% | $83.52 | +7.64% | 2 qtrssince 2020-Q2 | Decreased 0 |
Boston Scientific Corporation | 1M | $39.9M | 1.3% | $32.63 | +17.10% | 3 qtrssince 2020-Q1 | Decreased 0 |
MOLINA HEALTHCARE INC | 208,374 | $38.1M | 1.2% | $144.53 | +18.87% | 3 qtrssince 2020-Q1 | Decreased 0 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $3.2B across 45 positions as of Q3 2020. Top holdings: THC (15.2%), TAK (9.4%), BHC (7.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 7 new positions, 5 exits, 9 increased. Top move: TAK (INCREASED, conviction 63). Portfolio: $3.2B across 45 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR